About: http://data.cimple.eu/news-article/9157764ea424db18881a1d54e9d44dba2f15d6d88e8aed9cba112d0a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/9157764ea424db18881a1d54e9d44dba2f15d6d88e8aed9cba112d0a Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The European Commission, the bloc's executive arm, on Friday authorised the use of anti-viral drug remdesivir to treat the new coronavirus. "Today's authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus," EU Health Commissioner Stella Kyriakides said in a statement. "We are granting this authorisation less than a month after the application was submitted, showing clearly the EU's determination to respond quickly whenever new treatments become available," she said. At least two major US studies have shown that remdesivir can reduce the duration of hospital stays for COVID-19 patients. Washington authorised the emergency use of the medicine -- which was originally intended as a treatment for Ebola -- on May 1, followed by several Asian nations including Japan and South Korea. The green light comes on the recomendation of the European Medicines Agency which gave its conditional authorisation last week for the treatment of patients above 12 years of age who are suffering pneumonia and require extra oxygen. It said its assessment was based mainly based on data from a study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID). The research, published in the leading journal the New England Journal of Medicine in May, showed that injections of remdesivir speeded patient recovery compared with a placebo. On average it reduced patients' hospital stays from 15 days to 11. arp/txw
schema:headline	EU authorises use of remdesivir to treat coronavirus
schema:mentions	Oxygen therapy Stella Kowalski European Commission European Medicines Agency New England Antiviral drug Placebo Remdesivir Medication National Institute of Allergy and Infectious Diseases Pneumonia Allergy University of Washington Ebola virus disease South Korea Japan European Union Severe acute respiratory syndrome coronavirus 2 Address Resolution Protocol
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-03 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software